Skip to main content

Table 2 Comorbidities

From: Variable use of amiodarone is associated with a greater risk of recurrence of atrial fibrillation in the critically ill

Comorbidity

No recurrent AF

(n = 86)

Recurrent AF

(n = 91)

Total

(n = 177)

P

Myocardial infarction

17 (20)

26 (29)

43 (24)

0.22

Congestive cardiac failure

6 (7)

16 (18)

22 (12)

0.04

Peripheral vascular disease

14 (16)

26 (29)

40 (23)

0.07

Cerebrovascular disease

13 (15)

6 (7)

19 (11)

0.09

Dementia

4 (5)

1 (1)

5 (3)

0.20

Chronic pulmonary disease

26 (30)

32 (35)

58 (33)

0.52

Connective tissue disease

4 (5)

7 (8)

11 (6)

0.54

Peptic ulcer disease

5 (6)

4 (4)

9 (5)

0.74

Mild liver disease

3 (3)

6 (7)

9 (5)

0.74

Diabetes mellitus

14 (16)

11 (12)

25 (14)

0.52

Moderately severe renal disease

14 (16)

16 (18)

30 (17)

0.84

Diabetes mellitus – severe

3 (3)

3(3)

6 (3)

1.00

Any tumour

11 (13)

14 (15)

25 (14)

0.67

Leukaemia

3 (3)

9 (10)

12 (7)

0.13

Lymphoma

2 (2)

2 (2)

4 (2)

1.00

Moderately severe liver disease

1 (1)

2 (2)

3 (2)

1.00

Metastatic tumour

3 (3)

9 (10)

12 (7)

0.13

SIRS

47 (55)

62 (68)

109 (62)

0.09

Sepsis

28 (33)

36 (40)

64 (36)

0.35

Ischaemic heart disease

23 (27)

35 (38)

58 (33)

0.11

Hypertension

50 (58)

56 (62)

106 (60)

0.65

Hypokalaemia

29 (34)

31 (34)

60 (34)

1.00

Rheumatic heart disease

2 (2)

0 (0)

2 (1)

0.24

Mitral valve disease

7 (8)

2 (2)

9 (5)

0.09

Haemochromatosis

1 (1)

1 (1)

2 (1)

1.00

  1. Values are shown as number (%)
  2. AF Atrial fibrillation, SIRS systemic inflammatory response syndrome